[HTML][HTML] Glioma–Immune Cell Crosstalk in Tumor Progression

M Elguindy, JS Young, I Mondal, RO Lu, WS Ho - Cancers, 2024 - mdpi.com
Simple Summary The environment surrounding primary glioma brain tumors plays a critical
role in tumor development and progression. Immune cells are important constituents of this …

[HTML][HTML] The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma

M Sooreshjani, S Tripathi, C Dussold, H Najem… - Cancers, 2023 - mdpi.com
Simple Summary Despite multi-modal treatment consisting of surgery, chemotherapy, and
radiation, glioblastoma inevitably recurs due to its diffuse infiltrative nature. Anti-tumor …

[HTML][HTML] Glioblastoma-on-a-chip construction and therapeutic applications

Z Xie, M Chen, J Lian, H Wang, J Ma - Frontiers in Oncology, 2023 - frontiersin.org
Glioblastoma (GBM) is the most malignant type of primary intracranial tumor with a median
overall survival of only 14 months, a very poor prognosis and a recurrence rate of 90%. It is …

The spatial and single-cell analysis reveals remodeled immune microenvironment induced by synthetic oncolytic adenovirus treatment

G Liu, Q Hu, S Peng, H Ning, J Mai, X Chen, M Tao… - Cancer Letters, 2024 - Elsevier
Oncolytic viruses are multifaceted tumor killers, which can function as tumor vaccines to
boost systemic antitumor immunity. In previous study, we rationally designed a synthetic …

[HTML][HTML] Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and …

C Zhao, X Zhu, J Tan, C Mei, X Cai, F Kong - Biomedicine & …, 2024 - Elsevier
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor,
characterized by high heterogeneity, strong invasiveness, poor prognosis, and a low …

Targeting one‐carbon metabolism for cancer immunotherapy

X Ren, X Wang, G Zheng, S Wang… - Clinical and …, 2024 - Wiley Online Library
Abstract Background One‐carbon (1C) metabolism is a metabolic network that plays
essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to …

Cell-based therapies for glioblastoma: Promising tools against tumor heterogeneity

D Nehama, AS Woodell, SM Maingi… - Neuro …, 2023 - academic.oup.com
Glioblastoma (GBM) is a highly aggressive tumor with a devastating impact on quality-of-life
and abysmal survivorship. Patients have very limited effective treatment options. The …

Treatment options for advanced hepatocellular carcinoma: the potential of biologics

F Rossari, S Foti, S Camera, M Persano… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Advanced hepatocellular carcinoma (HCC) represents a significant global
health burden, whose treatment has been recently revolutionized by the advent of biologic …

[HTML][HTML] The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity

V Salemme, G Centonze, L Avalle, D Natalini… - Frontiers in …, 2023 - frontiersin.org
Breast cancer is a highly heterogeneous disease, at both inter-and intra-tumor levels, and
this heterogeneity is a crucial determinant of malignant progression and response to …

[HTML][HTML] Harnessing lentiviral vectors for in vivo gene therapy of liver metastases

G Giacca, L Naldini, ML Squadrito - Clinical and Translational …, 2024 - ncbi.nlm.nih.gov
Liver metastases (LMS) commonly arise from gastrointestinal tumors, such as colorectal
cancer (CRC) and pancreatic cancer (PDAC). The immunosuppressive environment of the …